Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapy.
Zambon A, Brown BG, Hokanson JE, Motulsky AG, Brunzell JD. Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapy. J Intern Med. 2006 Apr; 259(4):401-9.